The future of genomic medicine and its implications for RNA therapies
On this page :
About:
Organized by 黑料社's D2R Initiative and AReNa, Quebec's RNA hub, this symposium at the 92nd Acfas Congress, will focus on the potential and challenges of developing RNA therapies. The event seeks to create a collaborative environment where the community can come together to discuss major issues in the field. We will explore three topics: collaboration, ethics and equity, and data science.
The rapid development of RNA technology, highlighted by the successful creation of mRNA-based vaccines, underlines what can be achieved when scientists from around the world join forces, and industry and governments invest to accelerate scientific progress.
This is the beginning of a revolution that will enable the rapid, low-cost development of genomics-based RNA therapies for new viral diseases, diseases with high morbidity (e.g. cancer) and rare diseases; which are currently incurable or very expensive to treat.
Despite these advances, the development and commercialization of these therapies still face challenges, including the need for greater collaboration between researchers, healthcare and industry. The application of these therapeutic approaches, particularly with regard to Indigenous communities, requires community engagement and leadership to enable implementation that takes into account the realities of stakeholders and respect for the principles of health equity and research ethics.
Our symposium will address these key issues in the development of RNA-based therapies, with a focus on fostering collaboration, leveraging AI and data science, and ensuring ethical research practices.
Registration and tickets:
This is a hybrid event, taking place online and in person and will be delivered in french. To register, purchase your ACFAS tickets here:
Please note that tickets are required to attend ACFAS events.
Agenda
View the agenda on the ACFAS website:聽
|
12听:45 |
Registration & participants arrive |
|---|---|
|
13听:00 |
Introductions:
|
|
13听:35 |
Panel 1: Ethics and equity in RNA therapies: Balancing innovation and responsibility Moderated by聽Am茅lie Quesnel Vall茅e, 黑料社 笔补苍别濒颈蝉迟蝉听:
|
|
14听:35 |
Panel 2: The future of RNA research: The impact of data science and AI Moderated by Mathieu Bourgey, 黑料社 笔补苍别濒颈蝉迟蝉听:
|
|
15听:40 |
Panel 3: Collaborative innovations: Strengthening partnerships in RNA research Moderated by聽Thomas Duchaine, 黑料社 笔补苍别濒颈蝉迟蝉听:
|
|
16听:45 |
Closing remarks, Thomas Duchaine, 黑料社 |
|
17听:00-19听:00 |
Cocktail with聽D2R and聽AReNa |
Speakers
To learn more about the speakers, visit the french version of this page by clicking on "FR" in the top right corner of this page.聽